Brawn Biotech Ltd

NSE: BRAWN · BSE: 530207 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹25.50
Market cap: ₹7.65 Cr
Revenue (annual): ₹16.98 Cr
Net profit (annual): ₹0.94 Cr
P/E (TTM): 8.9×Sector 47.3×
Promoter holding: 52.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Other Announcement 2 Board Meeting Date 2 Debt & Borrowing 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

13 Apr 2026 17:35 IST BSE

Debt & Borrowing

Brawn Biotech Debt & Borrowing

Brawn Biotech Limited confirmed it does not meet the SEBI criteria to be classified as a Large Corporate as of March 31, 2025. The company reported zero outstanding borrowings under the framework. This annual regulatory disclosure ensures compliance with SEBI debt-raising norms for the 2026 financial year.

Read the filing ↗